Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Adrenal Disorders
Does the imaging finding of central necrosis of an adrenal tumor, biochemically confirmed as pheochromocytoma, increase the risk of malignancy?
Related Questions
How will the newer JCEM guidelines on primary aldosteronism (PA) impact your management and screening of PA?
Do you forgo adrenal imaging in a patient with primary hyperaldosteronism who has decided against surgery?
How do you manage insomnia in a patient with Cushing syndrome, considering that elevated nighttime cortisol levels may contribute to their sleep disturbances?
Do you recommend using a 24-hour urinary cortisol/urinary creatinine ratio over a 24 hour urine cortisol to screen patients for Cushing's syndrome?
How do you counsel patients on the likelihood of resolution of their hypertension post adrenalectomy for primary hyperaldosteronism?
Do you recommend checking plasma metanephrine levels during adrenal venous sampling to assist in assessing lateralization in primary aldosteronism?
How do you counsel younger patients regarding long-term radiologic monitoring of non-functional adrenal adenomas?
What is the likelihood of recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients who develop immunotherapy induced adrenal insufficiency?
Can norethindrone, depakote or olanzapine interfere with the results of the 1mg overnight dexamethasone suppression test for hypercortisolism screening?
Are there any differences in specificity or sensitivity of the ACTH stimulation test when cosyntropin is administered intravenously versus intramuscularly?
